Related references
Note: Only part of the references are listed.Evaluation of Serum 1,5 Anhydroglucitol Levels as a Clinical Test to Differentiate Subtypes of Diabetes
Aparna Pal et al.
DIABETES CARE (2010)
An investigation of serum concentration of apoM as a potential MODY3 marker using a novel ELISA
C. Cervin et al.
JOURNAL OF INTERNAL MEDICINE (2010)
A genetic diagnosis of HNF1A diabetes alters treatment and improves glycaemic control in the majority of insulin-treated patients
M. Shepherd et al.
DIABETIC MEDICINE (2009)
Association of C-reactive protein with type 2 diabetes: prospective analysis and meta-analysis
C. C. Lee et al.
DIABETOLOGIA (2009)
Update on Mutations in Glucokinase (GCK), Which Cause Maturity-Onset Diabetes of the Young, Permanent Neonatal Diabetes, and Hyperinsulinemic Hypoglycemia
Kara K. Osbak et al.
HUMAN MUTATION (2009)
An assessment of the joint associations of aspirin and statin use with C-reactive protein concentration
Matt Fisher et al.
AMERICAN HEART JOURNAL (2008)
Polymorphisms of the HNF1A gene encoding hepatocyte nuclear factor-1α are associated with C-reactive protein
Alexander P. Reiner et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2008)
Loci related to metabolic-syndrome pathways including LEPR, HNF1A, IL6R, and GCKR associate with plasma C-reactive protein:: The women's genome health study
Paul M. Ridker et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2008)
Clinical application of 1,5-anhydroglucitol measurements in patients with hepatocyte nuclear factor-1α maturity-onset diabetes of the young
Jan Skupien et al.
DIABETES CARE (2008)
Can complement factors 5 and 8 and transthyretin be used as biomarkers for MODY 1 (HNF4A-MODY) and MODY 3 (HNF1A-MODY)?
E. Karlsson et al.
DIABETIC MEDICINE (2008)
Best practice guidelines for the molecular genetic diagnosis of maturity-onset diabetes of the young
S. Ellard et al.
DIABETOLOGIA (2008)
A common haplotype of the glucokinase gene alters fasting glucose and birth weight: Association in six studies and population-genetics analyses
Michael N. Weedon et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2006)
β-cell dysfunction, insulin sensitivity, and glycosuria precede diabetes in hepatocyte nuclear factor-1α mutation carriers
A Stride et al.
DIABETES CARE (2005)
Serum amino acids in patients with mutations in the hepatocyte nuclear factor-1 alpha gene
A Stride et al.
DIABETIC MEDICINE (2004)
Genetic cause of hyperglycaemia and response to treatment in diabetes
ER Pearson et al.
LANCET (2003)
Clinical application of C-reactive protein for cardiovascular disease detection and prevention
PM Ridker
CIRCULATION (2003)
Regulation of apolipoprotein M gene expression by MODY3 gene hepatocyte nuclear factor-1 alpha - Haploinsufficiency is associated with reduced serum apolipoprotein M levels
S Richter et al.
DIABETES (2003)
Heterogeneity in young adult onset diabetes: aetiology alters clinical characteristics
KR Owen et al.
DIABETIC MEDICINE (2002)
The generalized aminoaciduria seen in patients with hepatocyte nuclear factor-1α mutations is a feature of all patients with diabetes and is associated with glucosuria
C Bingham et al.
DIABETES (2001)
Hepatocyte nuclear factor-1α is an essential regulator of bile acid and plasma cholesterol metabolism
DQ Shih et al.
NATURE GENETICS (2001)
Share Paper
